Swiss say more data needed on AstraZeneca jab

Swiss say more data needed on AstraZeneca jab

Swiss regulators said Wednesday that data submitted by AstraZeneca were not sufficient for it to authorise use of the Anglo-Swedish firm’s COVID-19 vaccine and “new studies” were needed.

Comments are closed.

Grapes could protect against sun damage, say dermatologists
3 February 2021
Unraveling the mystery of Gαo, a protein implicated in movement disorders
3 February 2021